Inflaming the Brain with Iron.

Area of Science:

• Neurobiology
• Neuroinflammation
• Iron Metabolism

Background:

• Iron accumulation and neuroinflammation are hallmarks of neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD).
• A complex interplay exists between iron and inflammation, influencing microglial and macrophage function, and impacting neuronal iron regulation.
• Key mediators like hepcidin and nitric oxide (·NO) play critical roles in this bidirectional relationship.

Purpose of the Study:

• To review and summarize the scientific findings connecting neuroinflammation and iron accumulation.
• To elucidate the causal association between these pathological processes in AD and PD.

Main Methods:

• Review of existing literature on iron metabolism and neuroinflammation in neurodegenerative diseases.
• Analysis of the roles of hepcidin and nitric oxide (·NO) in regulating iron homeostasis.
• Examination of the impact of nitric oxide-activated iron regulatory protein 1 (IRP1) on cellular iron balance.

Main Results:

• Hepcidin reduces iron export from neurons and brain entry by binding ferroportin 1 (Fpn1).
• Nitric oxide (·NO) converts cytosolic aconitase (c-aconitase) to iron regulatory protein 1 (IRP1), impairing iron homeostasis.
• This impairment leads to mitochondrial iron accumulation and neuronal death.

Conclusions:

• Neuroinflammation and iron accumulation are causally linked in the pathogenesis of AD and PD.
• Understanding this connection is crucial for developing therapeutic strategies targeting iron dysregulation in neurodegeneration.